Harbinger Health develops cancer diagnostic tests and recently presented new data for those tests at the American Association for Cancer Research (AACR) conference. The company announced a $100 million fundraising, reported on April 20, 2026. Public reporting tied the financing announcement to the AACR presentation, emphasizing both the capital event and the clinical or scientific data. The available coverage does not provide operating metrics, revenue figures, user counts, founding year, location, or detailed commercial plans. Reporting focused on the fundraising size and the new data disclosed at the conference.

Total raised

$290M

Funding rounds

3

Latest round

Equity

Latest activity

Apr 2026